Skip to main content
Equibles
SHC logo

SHC · Sotera Health Co

Track SHC — free

Use SHC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$18.90 -0.13 (-0.68%) At close · Sep 4
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$5.43B
Shares
285.37M

SHC metrics

81 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$18.90
Market cap
$5.43B

Price action

19 metrics
Price change (1W)
-2.3%
Price change (30D)
+0.6%
Price change (3M)
+22.2%
Price change (6M)
+26.4%
Price change (YTD)
+7.9%
Price change (1Y)
+19.1%
Trailing year
Price change (5Y)
-26.5%
52-week high
$19.57
52-week low
$13.13
Change from 52-week high
-2.8%
Change from 52-week low
+44.9%
Annualized volatility
29.0%
Beta
1.0
RSI (14D)
54.5
Price vs SMA 50
+4.0%
Price vs SMA 200
+13.3%
Avg volume (3M)
2.77M
Relative volume
0.9
Average dollar volume
$49.35M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
285.37M

Valuation

12 metrics
P / E (TTM)
33.4
Trailing earnings · reciprocal yield 3.0%
PEG ratio
0.1
EV / revenue
5.9×
reciprocal yield 16.9%
EV / EBITDA
—
EV / EBIT
24.8×
reciprocal yield 4.0%
P / sales
4.5×
reciprocal yield 22.4%
P / book
8.2
reciprocal yield 12.3%
FCF yield
2.1%
TTM · current market cap
Buyback yield
—
P / FCF
48.2
reciprocal yield 2.1%
P / operating cash flow
18.6
reciprocal yield 5.4%
Earnings yield
3.0%

Historical valuation

8 metrics
P / E historical average (3Y)
81.6×
reciprocal yield 1.2%
P / E historical average (5Y)
70.0×
reciprocal yield 1.4%
EV / revenue historical average (3Y)
5.4×
reciprocal yield 18.4%
EV / revenue historical average (5Y)
5.9×
reciprocal yield 17.1%
EV / EBIT historical average (3Y)
22.1×
reciprocal yield 4.5%
EV / EBIT historical average (5Y)
22.7×
reciprocal yield 4.4%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
55.0%
Operating margin
—
Trailing 12 months
Net margin
13.4%
Gross profit (TTM)
$668.51M
Operating profit (TTM)
$297.63M
Net income (TTM)
$163.48M
Trailing 12 months
Diluted EPS (TTM)
$0.57
FCF margin
9.3%
Effective tax rate
38.1%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+9.2%
Year over year
Net income growth YoY
+573.7%
Revenue (TTM)
$1.22B
Trailing 12 months
EPS growth YoY
+533.3%
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+5.1%
Revenue CAGR (5Y)
+7.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+16.0%
FCF CAGR (5Y)
+17.3%

Quality

14 metrics
Return on equity
24.6%
Return on assets
4.9%
Debt / equity
3.2
Current ratio
2.8
EBITDA (TTM)
—
Free cash flow (TTM)
$112.70M
Quick ratio
2.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$1.78B
Latest balance sheet
Cash & equivalents
$356.72M
Total assets
$3.31B
Total debt
$2.14B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$292.19M
Capital expenditures (TTM)
$179.49M
R&D (TTM)
—
SG&A (TTM)
$257.18M
Stock compensation (TTM)
$37.13M
R&D / revenue
—
Stock compensation / revenue
3.1%

Ownership (13F)

3 metrics
13F filers
320
13F filer change QoQ
+21
Institutional ownership
102.4%

Short interest

3 metrics
Short interest
4.2%
Latest settlement · 4.2 days to cover
Days to cover
4.2d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$24.00M
Insider-sentiment score
14 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1822479 CUSIP 83601L102 13F (30d) 225 filings 224 filers Visit website Investor relations